Vedanta Biosciences
About:
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Website: http://www.vedantabio.com
Twitter/X: vedantabio
Top Investors: Pfizer, Seventure Partners, Invesco, Bristol-Myers Squibb, KOREA INVESTMENT & SECURITIES
Description:
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.
$437M
$10M to $50M
Cambridge, Massachusetts, United States
2010-01-01
info(AT)vedantabio.com
Alexander Rudensky, Bernat Olle, Dan Littman, David Steinberg, Ruslan Medzhitov
101-250
2024-04-30
Private
© 2025 bioDAO.ai